Evaluation of Vitamin D Levels in Obese and Morbid Obese Children
Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 32870
Evaluation of Vitamin D Levels in Obese and Morbid Obese Children

Authors: Orkide Donma, Mustafa M. Donma


Obesity may lead to growing serious health problems throughout the world. Vitamin D appears to play a role in cardiovascular and metabolic health. Vitamin D deficiency may add to derangements in human metabolic systems, particularly those of children. Childhood obesity is associated with an increased risk of chronic and sophisticated diseases. The aim of this study is to investigate associations as well as possible differences related to parameters affected by obesity and their relations with vitamin D status in obese (OB) and morbid obese (MO) children. This study included a total of 78 children. Of them, 41 and 37 were OB and MO, respectively. WHO BMI-for age percentiles were used for the classification of obesity. The values above 99 percentile were defined as MO. Those between 95 and 99 percentiles were included into OB group. Anthropometric measurements were recorded. Basal metabolic rates (BMRs) were measured. Vitamin D status is determined by the measurement of 25-hydroxy cholecalciferol [25- hydroxyvitamin D3, 25(OH)D] using high-performance liquid chromatography. Vitamin D status was evaluated as deficient, insufficient and sufficient. Values < 20.0 ng/ml, values between 20-30 ng/ml and values > 30.0 ng/ml were defined as vitamin D deficient, insufficient and sufficient, respectively. Optimal 25(OH)D level was defined as ≥ 30 ng/ml. SPSSx statistical package program was used for the evaluation of the data. The statistical significance degree was accepted as p < 0.05. Mean ages did not differ between the groups. Significantly increased body mass index (BMI), waist circumference (C) and neck C as well as significantly decreased fasting blood glucose (FBG) and vitamin D values were observed in MO group (p < 0.05). In OB group, 37.5% of the children were vitamin D deficient, and in MO group the corresponding value was 53.6%. No difference between the groups in terms of lipid profile, systolic blood pressure (SBP), diastolic blood pressure (DBP) and insulin values was noted. There was a severe statistical significance between FBG values of the groups (p < 0.001). Important correlations between BMI, waist C, hip C, neck C and both SBP as well as DBP were found in OB group. In MO group, correlations only with SBP were obtained. In a similar manner, in OB group, correlations were detected between SBP-BMR and DBP-BMR. However, in MO children, BMR correlated only with SBP. The associations of vitamin D with anthropometric indices as well as some lipid parameters were defined. In OB group BMI, waist C, hip C and triglycerides (TRG) were negatively correlated with vitamin D concentrations whereas none of them were detected in MO group. Vitamin D deficiency may contribute to the complications associated with childhood obesity. Loss of correlations between obesity indices-DBP, vitamin D-TRG, as well as relatively lower FBG values, observed in MO group point out that the emergence of MetS components starts during obesity state just before the transition to morbid obesity. Aside from its deficiency state, associations of vitamin D with anthropometric measurements, blood pressures and TRG should also be evaluated before the development of morbid obesity.

Keywords: Children, morbid obesity, obesity, vitamin D.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1317246

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 942


[1] E. Lespessailles and H. Toumi, “Vitamin D alteration associated with obesity and bariatric surgery,” Exp Biol Med, vol.242, no. 10, pp. 1086-1094, May 2017.
[2] K. O. Alyahya, “Vitamin D levels in schoolchildren: a cross-sectional study in Kuwait,” BMC Pediatrics, vol.17, Dec.2017.
[3] L. S. Greene-Finestone, D. Garriguet, S. Brooks, K. Langlois, and S. J. Whiting, “Overweight and obesity are associated with lower vitamin D status in Canadian children and adolescents,” Paediatr Child Health, vol. 22, no. 8, pp. 438-444, Dec. 2017.
[4] J. S. Walsh, S. Bowles, and A. L. Evans, “Vitamin D in obesity,” Curr Opin. Endocr. Diabetes Obesity, vol. 24, no. 6, pp. 389-394, Dec. 2017.
[5] L. Barrea, S. Savastano, C. Di Somma, M. C. Savanelli, F. Nappi, L. Albanese, F. Orio, and A. Colao, “Low serum vitamin D-status, air pollution and obesity: A dangerous liaison,” Rev Endocr Metab Disorders, vol. 18, No. 2, pp. 207-214, Jun. 2017.
[6] S. Savastano, L. Barrea, M. C. Savanelli, F. Nappi, C. Di Somma, F. Orio, A. Colao, “Low vitamin D status and obesity: Role of nutritionist,” Rev Endocr Metab Disorders, vol. 18, no. 2, pp. 215-225, Jun. 2017.
[7] T. Dura-Trave, F. Gallinas-Victoriano, M. J. Chueca-Guindulain, and S. Berrade-Zubiri, “Prevalence of hypovitaminosis D and associated factors in obese Spanish children,” Nutr Diabetes, vol.7, article no. e248, Mar. 2017.
[8] M. J. Alkhatatbeh, K. K. Abdul-Razzak, L. Q. Khasawneh, and N. A. Saadeh, “High prevalence of vitamin D deficiency and correlation of serum vitamin D with cardiovascular risk in patients with metabolic syndrome,” Metab Syndr Relat Disord, vol. 15, no.5, pp. 213-219, Jun. 2017.
[9] A. Mousa, N. Naderpoor, M. P. J. de Courten, R. Scragg, and B. de Courten, “25-hydroxyvitamin D is associated with adiposity and cardiometabolic risk factors in a predominantly vitamin D-deficient and overweight /obese but otherwise healthy cohort,” J Steroid Biochem Mol Biol, vol.173, pp. 258-264, Oct. 2017.
[10] A. Gul, S. Ozer, R. Yilmaz, E. Sonmezgoz, T. Kasap, S. Takci, and O. Demir, “Association between vitamin D levels and cardiovascular risk factors in obese children and adolescents,” Nutr Hospital, vol. 34, no.2, pp. 323-329, Mar.-Apr. 2017.
[11] M. Erol, O. B. Gayret,S. Hamilcikan, E. Can, O. Yigit, “Vitamin D deficiency and insulin resistance as risk factors for dyslipidemia in obese children,” Arch Argent Ped, vol. 115, no. 2, pp. 133-138, Apr. 2017
[12] T. Grunwald, S. Fadia, B. Bernstein, M. Naliborski, S. F. Wu, and F. De Luca, “Vitamin D supplementation, the metabolic syndrome and oxidative stress in obese children,” J Ped Endocrinol Metab, vol. 30, no. 4, pp. 383-388, Apr. 2017.
[13] J. Leger-Guist'hau,C. Domingues-Faria, M. Miolanne, F. Peyrol, L. Gerbaud, B. Perreira, R. Minet-Quinard, V. Sapin, S. Walrand, and Y. Boirie, “Low socio-economic status is a newly identified independent risk factor for poor vitamin D status in severely obese adults,” J Hum Nutr Diet, vol. 30, no. 2, pp. 203-215, Apr. 2017.
[14] G. Cediel, C. Corvalan, D. L. de Romana, V. Mericq, and R. Uauy, “Prepubertal adiposity, vitamin D status and insulin resistance,” Pediatrics, vol. 138, no. 1, e20160076, Apr. 2016.
[15] L. L. Munasinghe, Y. Yuan, N. D. Willows, E. L. Faught, J. P. Ekwaru, and P. J. Veugelers, “Vitamin D deficiency and sufficiency among Canadian children residing at high latitude following the revision of the RDA of vitamin D intake in 2010,” Br J Nutr, vol. 117, no. 3, pp. 457-465, Feb. 2017.
[16] I. M. Kaddam, A. M. Al-Shaikh, B. A. Abaalkhail, K. S. Asseri, Y. M. Al-Saleh, A. A. Al-Qarni, A M. Al-Shuaibi, W. G. Tamimi, and A. M. Mukhtar, “Prevalence of vitamin D deficiency and its associated factors in three regions of Saudi Arabia A cross-sectional study,” Saudi Med J, vol. 38, no. 4, pp. 381-390, Apr. 2017.
[17] C. Legarth, D. Grimm, M. Wehland, J. Bauer, and M. Krüger, “The impact of vitamin D in the treatment of essential hypertension,” Int J Mol Sci, vol. 19, no. 2, pii. E455, Feb. 2018.
[18] J. S. R. Moreira, T. P. de Paula, L. F. Sperb, M. E. P. Miller, M. J. Azevedo, and L. V. Viana, “ Asociation of plasma vitamin D status with lifestyle patterns and ambulatory blood pressure monitoring parameters in patients with type 2 diabetes and hypertension,” Diab Res Clin Pract, vol.139, pp. 139-146, Mar. 2018.
[19] A. Gupta, M. Aslam, S. Rathi, B. K. Mishra, S. Bhardwai, R. Jhamb, and S. V. Madhu, “ Association of vitamin D levels and type 2 diabetes mellitus in Asian Indians is independent of obesity,” Exp Clin Endocrinol Diabetes, 2018 Mar 20 (Epub ahead of print).
[20] www.heart.org (Accessed on: 06/10/2016).
[21] J. Y. Shin, and C. H. Ha, “Relationships between blood pressure and health and fitness-related variables in obese women,” J Phys Ther Sci, vol. 28, pp. 2933-2937, Jul. 2016.
[22] N. Ali, S. Mahmood, M. Manirujjaman, R. Perveen, A Al Nahid, S. Ahmed, F. A. Khanum, and M. Rahman, “Hypertension prevalence and influence of basal metabolic rate on blood pressure among adult students in Bangladesh,” BMC Public Health, vol. 18, pp.58, 2018.
[23] T. Chen, X. Chu, Y. Zhu, Y. Lan, H. Zhao, and C. Shen, “ Basal metabolic rate is correlated with blood pressure among young population,” Int J Clin Exp Med, vol. 9, no. 6, pp. 12375-12383, 2016.
[24] J. J. Snodgrass, W. R. Leonard, M. V. Sorensen, L. A. Tarskaia, and M. J. Mosher, “ The influence of basal metabolic rate on blood pressure among indigenous Siberains,” Am J Phys Anthropol, vol. 137, pp. 145-155, Mar.2008.